BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32590067)

  • 21. Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage.
    Caldwell JR; Roth SH; Wu WC; Semble EL; Castell DO; Heller MD; Marsh WH
    Am J Med; 1987 Sep; 83(3B):74-82. PubMed ID: 3310631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NSAID-related gastrointestinal complications.
    Soll AH; McCarthy D
    Clin Cornerstone; 1999; 1(5):42-56. PubMed ID: 10682181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capsaicin as new orally applicable gastroprotective and therapeutic drug alone or in combination with nonsteroidal anti-inflammatory drugs in healthy human subjects and in patients.
    Mózsik G
    Prog Drug Res; 2014; 68():209-58. PubMed ID: 24941671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonsteroidal anti-inflammatory drugs: how do they damage gastroduodenal mucosa?
    Scarpignato C
    Dig Dis; 1995 Jan; 13 Suppl 1():9-39. PubMed ID: 7697906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protocatechuic acid-mediated DJ-1/PARK7 activation followed by PI3K/mTOR signaling pathway activation as a novel mechanism for protection against ketoprofen-induced oxidative damage in the gastrointestinal mucosa.
    Cheng YT; Lin JA; Jhang JJ; Yen GC
    Free Radic Biol Med; 2019 Jan; 130():35-47. PubMed ID: 30326282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal lesions during treatment with non-steroidal anti-inflammatory drugs (NSAIDs).
    Festen HP
    Neth J Med; 1989 Dec; 35(5-6):327-33. PubMed ID: 2699655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-steroidal anti-inflammatory drug gastropathy: causes and treatment.
    Hawkey CJ
    Scand J Gastroenterol Suppl; 1996; 220():124-7. PubMed ID: 8898449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indomethacin enhances bile salt detergent activity: relevance for NSAIDs-induced gastrointestinal mucosal injury.
    Petruzzelli M; Moschetta A; Renooij W; de Smet MB; Palasciano G; Portincasa P; van Erpecum KJ
    Dig Dis Sci; 2006 Apr; 51(4):766-74. PubMed ID: 16615001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
    Agrawal NM; Saggioro A
    J Rheumatol Suppl; 1991 Mar; 28():15-8. PubMed ID: 1674754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
    Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
    Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of NSAID-induced gastroenteropathy.
    Price AH; Fletcher M
    Drugs; 1990; 40 Suppl 5():1-11. PubMed ID: 2081486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by aspirin but not indomethacin.
    Slomiany BL; Piotrowski J; Slomiany A
    J Endotoxin Res; 2001; 7(3):203-9. PubMed ID: 11581571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metabolism of non-steroidal anti-inflammatory drugs by peroxidase: implication for gastrointestinal mucosal lesions].
    Muraoka S; Miura T
    Yakugaku Zasshi; 2007 Apr; 127(4):749-56. PubMed ID: 17409707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of nonsteroidal antiinflammatory drugs on upper gastrointestinal tract symptoms and mucosal integrity.
    Katzka DA; Sunshine AG; Cohen S
    J Clin Gastroenterol; 1987 Apr; 9(2):142-8. PubMed ID: 3553307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NSAIDs: a critical appraisal.
    Jacobs JW; Bijlsma JW
    Neth J Med; 1997 Dec; 51(6):198-204. PubMed ID: 9499690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phytochemicals enhance antioxidant enzyme expression to protect against NSAID-induced oxidative damage of the gastrointestinal mucosa.
    Cheng YT; Lu CC; Yen GC
    Mol Nutr Food Res; 2017 Jun; 61(6):. PubMed ID: 27883262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandins, NSAIDS, and GI mucosal integrity: can we identify patients at risk of NSAID-induced gastric injury?
    Dajani EZ
    Am J Gastroenterol; 1996 May; 91(5):835-6. PubMed ID: 8633566
    [No Abstract]   [Full Text] [Related]  

  • 38. Endoscopic aspects of gastroduodenal mucosa due to NSAIDs.
    Ruina M; Caselli M; Sartori S; Trevisani L; La Corte R; Trotta F; Alvisi V
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():9-11. PubMed ID: 9032574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention by parenteral aspirin of indomethacin-induced gastric lesions in rats: mediation by salicylic acid.
    Komoike Y; Takeeda M; Tanaka A; Kato S; Takeuchi K
    Dig Dis Sci; 2002 Jul; 47(7):1538-45. PubMed ID: 12141814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [NSAID-induced damage to the gastrointestinal mucosa].
    Rodonezhskaia EV; Kharchenko NV
    Lik Sprava; 2001; (4):179-80. PubMed ID: 11692710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.